IL1B and non-small cell lung carcinoma: We have now revealed an indispensable role for IL-1β in the upregulation of PD-L1 expression in NSCLC cells, suggesting the possibility that IL-1β might increase the incidence and mortality of NSCLC, consistent with the findings of the CANTOS study.